Perspective Therapeutics
Price & Volume
Stats
See moreOpen | $2.26 |
Previous Close | $2.23 |
Day Range | $2.26-$2.38 |
52W Range | $1.60-$5.39 |
Market Cap | $165.7M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | -43.4% |
Gross Profit (12 Mos) | -$60.8M |
Diluted EPS | -$1.51 |
News
See moreYahoo Finance • 18 days ago
Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results
Yahoo Finance • last month
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
Yahoo Finance • 3 months ago
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors
About
CEO | Mr. Johan M. Spoor |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 138 |
